Transplant Nephrology Clinic Note – initial outpatient follow-up; target tacrolimus trough 8–10 ng/mL

Date: 06/13/2025

Subjective:
Patient presents for first post-discharge clinic visit. Reports good energy, mild tremor in hands, incisional soreness improving. Taking all medications as prescribed, using pillbox. No fevers, no dysuria, no swelling.

Objective:
- Vitals: BP 138/84, HR 76, afebrile.
- Exam: Incision healing well, no erythema or drainage. No LE edema. Lungs clear.
- Labs: Cr 1.5 mg/dL, BUN 22, tacrolimus trough 9.2 ng/mL, WBC 7.8, Hgb 10.2. UA: trace protein, no hematuria.
- Weight: stable.

Assessment/Plan:
1. Excellent early graft function, stable creatinine.
2. Tacrolimus trough therapeutic (goal 8–10). Continue 3 mg BID.
3. Continue MMF 1 g BID and prednisone 20 mg daily.
4. Prophylaxis: continue valganciclovir, TMP-SMX.
5. Monitor BP at home, continue amlodipine and labetalol.
6. Repeat labs twice weekly x 2 weeks.
